Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Introduction: VVI is a frequent complaint of women of child bearing age. Common causes of VVI include bacterial vaginosis,
vulvovaginal candidiasis and trichomoniasis. Toll-like receptors and C-type lectins (CLR) play a major role in recognition of
molecular patterns of these pathogens. Mannose Binding Lectin-2 (MBL-2) is asoluble CLR which triggers the complement
cascade by binding to carbohydrate moieties on the surface of microorganisms. The MBL-2 codon 54 polymorphism has
been associated with increased rate of recurrent vulvovaginal candidiasis. The objective of the present study was to evaluate
promoter polymorphism of MBL-2 gene in VVI patients.
Materials & Methods: Blood samples were collected from 203 VVI patients as well as matched healthy subjects� in EDTA-coated
vials. Three single nucleotide polymorphisms (SNPs) in promoter region i.e., H/L, Y/X and P/Qwere analyzed by Amplification
Refractory Mutation System-PCR (ARMS-PCR). The odds ratios (ORs) were calculated using MedCalc software.
Results: Significant difference were observed in genotypic as well as allelic frequencies of Y/X polymorphism (p<0.01). X allele
was found to be protective factor for VVI patients (OR: 0.5553, 95% CI: 0.4147 to 0.7436, p<0.001). The dominant and codominant
models gave the most parsimonious fit for MBL-2Y/X polymorphism (p<0.001). However, no significant differences
was observed in genotypic as well as allelic frequencies of H/LandP/Q polymorphisms (p>0.05).
Conclusion: The present study showed thatY/Xpolymorphism of MBL-2 gene may be a protective factor for VVI.